Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 3:08 pm Purchase |
2021-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST |
Cormorant Asset Management LP | 5,440,451 9.770% |
325,607![]() (+6.37%) |
Filing History |
2022-02-14 3:07 pm Sale |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
Cormorant Asset Management LP | 2,038,215 5.770% |
-253,845![]() (-11.07%) |
Filing History |
2022-02-14 3:06 pm Sale |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,012,115 4.290% |
-452,432![]() (-18.36%) |
Filing History |
2022-02-14 3:05 pm Sale |
2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Cormorant Asset Management LP | 1,679,442 2.020% |
-4,731,913![]() (-73.81%) |
Filing History |
2022-02-14 3:04 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Cormorant Asset Management LP | 1,436,322 6.280% |
1,436,322![]() (New Position) |
Filing History |
2022-02-14 3:04 pm Sale |
2021-12-31 | 13G | Otonomy, Inc. OTIC |
Cormorant Asset Management LP | 0 0.000% |
-2,600,000![]() (Position Closed) |
Filing |
2022-02-14 3:03 pm Sale |
2021-12-31 | 13G | Omeros Corporation OMER |
Cormorant Asset Management LP | 0 0.000% |
-5,000,000![]() (Position Closed) |
Filing History |
2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
Cormorant Asset Management LP | 3,025,000 6.110% |
632,703![]() (+26.45%) |
Filing History |
2022-02-14 3:01 pm Sale |
2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Cormorant Asset Management LP | 2,169,871 5.390% |
-1,025,673![]() (-32.10%) |
Filing History |
2022-02-14 3:01 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cormorant Asset Management LP | 1,403,331 6.790% |
-310,938![]() (-18.14%) |
Filing History |
2022-02-14 3:00 pm Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Cormorant Asset Management LP | 1,428,598 9.900% |
1,428,598![]() (New Position) |
Filing History |
2021-08-13 4:01 pm Purchase |
2021-08-03 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 2,252,628 8.830% |
2,252,628![]() (New Position) |
Filing History |
2021-08-10 4:01 pm Unchanged |
2021-07-26 | 13D | Erasca, Inc. ERAS |
Cormorant Asset Management LP | 10,505,553 8.830% |
0 (Unchanged) |
Filing History |
2021-07-30 4:01 pm Purchase |
2021-07-20 | 13D | Erasca, Inc. ERAS |
Cormorant Asset Management LP | 10,505,553 8.830% |
10,505,553![]() (New Position) |
Filing History |
2021-07-12 4:19 pm Purchase |
2021-07-02 | 13G | Aerovate Therapeutics, Inc. AVTE |
Cormorant Asset Management LP | 58,020 8.320% |
58,020![]() (New Position) |
Filing History |
2021-07-09 4:06 pm Purchase |
2021-06-29 | 13G | Elevation Oncology, Inc. ELEV |
Cormorant Asset Management LP | 1,983,168 8.690% |
1,983,168![]() (New Position) |
Filing History |
2021-07-08 4:02 pm Purchase |
2021-06-28 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
Cormorant Asset Management LP | 3,193,974 7.180% |
3,193,974![]() (New Position) |
Filing History |
2021-07-02 4:12 pm Purchase |
2021-06-22 | 13G | Ambrx Biopharma Inc. AMAM |
Cormorant Asset Management LP | 17,404,702 6.600% |
17,404,702![]() (New Position) |
Filing History |
2021-05-19 4:09 pm Purchase |
2021-05-18 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 3,675,000 5.000% |
1,179,934![]() (+47.29%) |
Filing History |
2021-04-09 4:07 pm Purchase |
2021-03-30 | 13G | Constellation Pharmaceuticals, Inc. CNST |
Cormorant Asset Management LP | 5,114,844 9.200% |
5,114,844![]() (New Position) |
Filing History |